Marshall Wace
TMCI icon

Marshall Wace’s Treace Medical Concepts TMCI Stock Holding History

Marshall Wace’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.29M Buy
1,328,592
+1,063,659
+401% +$2.92M ﹤0.01% 1346
2026
Q1 		$355K Buy
+264,933
New +$528K ﹤0.01% 2597
2025
Q4 		– Sell
-11,758
Closed -$78.9K – 3480
2025
Q3 		$78.9K Sell
11,758
-124,119
-91% -$810K ﹤0.01% 2685
2025
Q2 		$799K Buy
135,877
+97,729
+256% +$637K ﹤0.01% 1943
2025
Q1 		$320K Sell
38,148
-50,762
-57% -$456K ﹤0.01% 2243
2024
Q4 		$661K Sell
88,910
-337,820
-79% -$2.26M ﹤0.01% 1925
2024
Q3 		$2.48M Sell
426,730
-36,309
-8% -$233K ﹤0.01% 1287
2024
Q2 		$3.08M Buy
463,039
+183,921
+66% +$1.49M ﹤0.01% 1188
2024
Q1 		$3.64M Sell
279,118
-258,372
-48% -$3.44M 0.01% 1127
2023
Q4 		$6.85M Buy
537,490
+504,959
+1,552% +$5.1M 0.01% 797
2023
Q3 		$426K Buy
+32,531
New +$595K ﹤0.01% 1774
2023
Q2 		– Sell
-282,905
Closed -$7.13M – 2963
2023
Q1 		$7.13M Buy
+282,905
New +$6.64M 0.02% 840
2022
Q4 		– Sell
-23,707
Closed -$524K – 3426
2022
Q3 		$524K Buy
+23,707
New +$459K ﹤0.01% 2704
2022
Q1 		– Sell
-33,908
Closed -$633K – 4021
2021
Q4 		$633K Buy
+33,908
New +$700K ﹤0.01% 2683

Other funds holding TMCI

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CBU
CIBC Bancorp USA Chicago, Illinois $82.3B AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Marshall Wace's TMCI Position: Q2 2026 in Review

Marshall Wace increased its Treace Medical Concepts (TMCI) stake by 401% in Q2 2026, buying an estimated $2.92M and bringing the position to 1,328,592 shares worth $5.29M. The position accounts for ﹤0.01% of the portfolio, ranked #1346.

Marshall Wace first reported a position in TMCI in Q4 2021 and has held it in 14 quarters since. The position peaked at $7.13M in Q1 2023. 117 funds tracked by Wall St. Rank hold TMCI as of Q2 2026.

  • Marshall Wace held 1,328,592 shares of Treace Medical Concepts worth $5.29M as of Q2 2026.
  • Marshall Wace bought 1,063,659 Treace Medical Concepts shares in Q2 2026, an estimated $2.92M.
  • Treace Medical Concepts made up ﹤0.01% of Marshall Wace's portfolio in Q2 2026, its #1346 holding.
  • Marshall Wace first reported a position in Treace Medical Concepts in Q4 2021 and has held it in 14 quarters since.
  • Marshall Wace's Treace Medical Concepts position peaked at $7.13M in Q1 2023.
  • 117 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.